These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 480401)

  • 21. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
    Trachtman H; Zavilowitz B; Bennett B; Goldsmith DI
    Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
    Weening JJ; Grond J; Hoedemaeker PJ
    Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR; Mauer SM; Michael AF
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine protease and antiprotease activity in experimental aminonucleoside nephrotoxicity.
    Mayer M; Yedgar S; Joffe M; Shafrir E
    Nephron; 1981; 29(5-6):223-8. PubMed ID: 7033808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered localization of protamine-heparin complexes in aminonucleoside nephrosis.
    Seiler MW; Hoyer JR; Krueger TE
    Lab Invest; 1980 Jul; 43(1):9-17. PubMed ID: 6993788
    [No Abstract]   [Full Text] [Related]  

  • 27. Zinc metabolism in aminonucleoside-induced nephrosis.
    Freeman RM; Richards CJ; Rames LK
    Am J Clin Nutr; 1975 Jul; 28(7):699-703. PubMed ID: 1146720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR; Meline JA; Ni RX; Keys M; Wu CH
    Am J Pathol; 1987 Oct; 129(1):133-9. PubMed ID: 3499082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
    Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T; Kaneko K; Yamada T; Yamashiro Y
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis.
    Ryan GB; Rodewald R; Karnovsky MJ
    Lab Invest; 1975 Nov; 33(5):461-8. PubMed ID: 1186127
    [No Abstract]   [Full Text] [Related]  

  • 34. Status of glomerular proteoglycans in aminonucleoside nephrosis.
    Lelongt B; Makino H; Kanwar YS
    Kidney Int; 1987 Jun; 31(6):1299-310. PubMed ID: 2441105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DMSO potentiates aminonucleoside of puromycin nephrosis in rats.
    Spear GS; Nguyen D; Conklin S; Wikle JS; Fan J; Lan YH; Allen J; Reineck S
    J Pathol; 1987 Oct; 153(2):183-7. PubMed ID: 3694323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary kallikrein in experimental renal disease.
    Glasser RJ; Michael AF
    Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for oxygen free radicals in aminonucleoside nephrosis.
    Diamond JR; Bonventre JV; Karnovsky MJ
    Kidney Int; 1986 Feb; 29(2):478-83. PubMed ID: 3702206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micropuncture study of fluid transfer in aminonucleoside nephrosis in the rat.
    Lewy JE
    Pediatr Res; 1976 Jan; 10(1):30-4. PubMed ID: 1246462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.